iShares Nasdaq US Biotechnology UCITS ETF (BTEC.L) — ETF Analysis on Winston
Key Facts
- Issuer: IShares
- Asset Class: Stock
- Price: $9.61
- Expense Ratio: 35.00%
- Assets Under Management: $1.1B
- Number of Holdings: 255
- Inception Date: 2017-10-19
- Currency: GBP
Winston Score
iShares Nasdaq US Biotechnology UCITS ETF has a Winston Score of 72 out of 100.
Performance
- 1-Year Return: 41.49%
- 3-Year Return: 44.14%
- 5-Year Return: 20.48%
Top Holdings
VERTEX PHARMACEUTICALS INC (N/A%), AMGEN INC (N/A%), GILEAD SCIENCES INC (N/A%), REGENERON PHARMACEUTICALS INC (N/A%), ALNYLAM PHARMACEUTICALS INC (N/A%)
Sector Breakdown
Healthcare (N/A%)